На главную
Результаты поиска “University of pennsylvania hospital prostate cancer”
Alan J. Wein, MD, PhD (Hon) - Urologist, Penn Medicine
Watch an interview with Alan J. Wein, MD, PhD (Hon), Chief of Urology at the Hospital of the University of Pennsylvania, and the Founder's Professor of Urology, and the Chief of the Division of Urology at Penn Medicine. "Innovation has always been one of the strong suits here at Penn, and in urology we endeavor to translate innovative techniques into common clinical practice." "I see patients mostly with urologic cancer, that is carcinoma of the prostate, it's probably the most common thing I see. Every patient should get the benefit of the expertise of the institutions. So if you put together the expertise of the 15 people, we truly cover every single area in adult urology with someone who is truly an expert and specifically trained in that area as well as the other areas of adult urology." "We now have four fully-trained robotic surgeons on staff, and each of the three hospitals; Pennsylvania Hospital, Presbyterian Penn Medical Center and the Hospital, the University of Pennsylvania, has trained robotics surgeons there that can do cancer robotic surgery on prostate, on bladder, on kidney." "We like to think of ourselves as an organ preservation center where we can, so in other words, kidney-sparing operations for kidney cancer, bladder-sparing operations and protocols for bladder cancer, obviously, the application of proton therapy to prostate cancer, a huge innovation; the largest proton treatment center in the world right across the street there, you know, just waiting to accept prostate cancer patients who are applicable for that and who want that therapy over others." "We're constantly trying to apply what has been proven to be applicable, successful, effective, have minimal risks to our patients, not just with cancer but with every other malady that we treat. If something is new and exciting, if it has backup to show that it's effective, then we'll apply it in our patients. We'll be the first in the area to do that, always." "I'm Alan Wein. I'm the Chief of Urology here at the Hospital of the University of Pennsylvania, and the Founder's Professor of Urology, and the Chief of the Division of Urology at Penn Medicine." Learn more about Dr. Wein: http://www.pennmedicine.org/Wagform/MainPage.aspx?config=provider&P=PP&ID=1852 To learn more, visit http://www.pennmedicine.org/urology
Просмотров: 5760 Penn Medicine
David I. Lee, MD - Urologist, Penn Medicine
Watch an interview with David I. Lee, MD, the Chief of Urology at Penn Presbyterian Medical Center, and Assistant Professor of Urology at Penn Medicine. "My specialty is urology, but within urology I have a very narrow focus, which is minimally invasive prostate cancer surgery. And so I was lucky enough to be on the forefront of the experience with this technique and technology of robotic assistance surgery." "I've done over 2,200 of these robotic processes, technically operations, to date. This is one of the biggest experiences in the world with this procedure, and by far, the biggest experience in the local Philadelphia area." "Experience really sets us apart at Penn Medicine. I think that's the benefit to the patient, where we have clinicians who are very experienced at providing minimally invasive surgery for prostate cancer, for bladder cancer, for kidney cancer." "What gives me the most satisfaction after having done all of these operations is the very smooth course that most of the patients go through. The patients very often comment to me that they had zero pain going through the whole procedure. I still find that very difficult to believe sometimes, but I've had so many patients tell me that, that I really do believe it now." "I'm David Lee. I'm Chief of Urology at Penn Presbyterian Medical Center, and Assistant Professor of Urology at Penn Medicine." Learn more about Dr. Lee: http://www.pennmedicine.org/Wagform/MainPage.aspx?config=provider&P=PP&ID=9776 To learn more, visit http://www.pennmedicine.org/urology
Просмотров: 8809 Penn Medicine
Geneva  University Hospital : Prostate Cancer Center
The prostate Cancer Center at Geneva University Hospital (HUG - Hôpitaux Universitaires de Genève) has inaugurated a multidisciplinary Prostate Cancer Center. It aims to provide an integrated care of prostate cancer patients with the best possible quality standards. HUG is also the first center in Western Switzerland to obtain a specific certification / quality label by the German Cancer Society. Mor information on : http://www.hug-ge.ch/centre-oncologie/centre-de-la-prostate
Просмотров: 1271 Hopitaux Universitaires de Genève
David I. Lee, MD performs daVinci Prostatectomy (DVP)
David Lee, MD, Chief of Urology at Penn Presbyterian Medical Center performs a robotic prostatectomy in Seoul, Korea as a case demonstration. The hosting hospital was Asan Medical Center in Seoul, Korea.
Просмотров: 42343 Penn Medicine
Victor L. Carpiniello, MD, FACS - Urologist, Penn Medicine
Watch an interview with Victor L. Carpiniello, MD, FACS, a urologist at Penn Medicine. "Sometimes I'm asked why I went into urology and what I enjoy about urology. Specifically, here at Pennsylvania Hospital, I enjoy the community." "It's very important to me to be a part of Penn Medicine because we offer such a wide range of treatments; we have robotic surgery, we have laproscopic surgery, we have incontinence treatment at an advance level, and we have also general urology. Penn Medicine offers me a academic position where I can be involved with teaching residence in urology as well as medical students that come down to Pennsylvania Hospital from the University." "My name is Dr. Victor Carpiniello. I'm part of the Division of Urology in the Penn Health System. I'm an Associate Professor of Urology at the University of Pennsylvania Medical School." Learn more about Dr. Carpinello: http://www.pennmedicine.org/Wagform/MainPage.aspx?config=provider&P=PP&ID=918 To learn more, visit http://www.pennmedicine.org/urology
Просмотров: 3707 Penn Medicine
Head and Neck Cancer Survivor | Mark's Story
Mark found a lump in the neck and was diagnosed with squamous cell carcinoma of the neck. Mark did his research for the top- rated institutions in the country who treated Head and Neck Cancer. He chose to go to Penn Medicine. At Penn he met Dr. Weinstein, who recommended TransOral Robotic Surgery (TORS). TORS, was invented at Penn is the world’s first minimally invasive surgery t techniques that enable Penn surgeons to remove benign and malignant tumors of the mouth and throat. Mark’s tumor was removed while preserving his ability to speak and swallow. Penn recommended Mark for Proton Therapy at the Roberts Proton Therapy Center. Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy the DNA of cancer cells. Today Mark is cancer-free.
Просмотров: 3363 Penn Medicine
Penn Medicine Stands Up To Cancer :30
Members of the Stand Up To Cancer Pancreatic Dream Team at Penn Medicine are translating scientific breakthroughs into new treatment options for patients faster than ever before. Watch the video to learn more Penn's involvement in SU2C. Penn Medicine's Abramson Cancer Center is second in the United States for cancer research funding from the National Institutes of Health, and in the top five nationally for research funding from the National Cancer Institute. As part of the Abramson Cancer Center, cancer researchers at Penn Medicine are at the forefront of developing new, personalized approaches to cancer treatment including treatments for pancreatic cancer. Cancer researchers at Penn seek to increase cancer survival rates, discover new cancer causes, and improve cancer prognoses for patients. It's because of this dedication to cancer research and clinical care for cancer patients that Penn Medicine was chosen as the lead site to coordinate a "dream team" that focuses on pancreatic cancer research and treatment. Watch the video to learn more about Penn Medicine's involvement in Stand Up to Cancer.
Просмотров: 123 Penn Medicine
Naomi B. Haas, MD, explains how cabozantinib is being integrated into treatment of renal cell cancer
Dr. Haas, Director, Prostate and Kidney Cancer Program, Associate Professor of Medicine at the Hospital of the University of Pennsylvania, tells us how cabozantinib is being integrated into the treatment of previously untreated, advanced renal cell cancer patients.
Просмотров: 43 OBRoncology
The Cardio-Oncology Program at Penn Medicine
Dr. Michael Acker, chief of the division of cardiovascular surgery, discusses cardio-oncology, an emerging field in cardiovascular medicine. This specialty was developed to respond to the growing need for clinicians with expertise in both cancer and cardiology. Lymphomas, such as Hodgkin's lymphoma, have been successfully treated with radiation and chemotherapy. However, the radiation used to treat lymphoma patients in the 70s, 80s and early 90s damaged the heart while treating the cancer, leading this group of patients to develop heart failure later in life. As cancer clinicians and researchers have developed breakthroughs and treatments that allow patients to live longer, there is an increasing need for specialists that understand both cancer and cardiology and can treat the side effects cancer treatment may have on the heart. Some of the nation’s leading cardio-oncology specialist are at Penn Medicine, including Dr. Joseph Carver, who leads our cardio-oncology program. The program partners with cardiac surgery to provide a unique expertise not available elsewhere. Learn more about the Penn Cardio-Oncology Program: http://bit.ly/2j2bkgb Meet Dr. Acker: http://bit.ly/2fkqolE Meet Dr. Carver: http://bit.ly/2j9WgL3 View the cardio-oncology team list: http://bit.ly/2j2mkKp
Просмотров: 496 Penn Medicine
TOP 10 Cancer Treatment Hospitals In The World
Top 10 Best Cancer Treatment Hospitals In The World Cancer is one of the most difficult diseases to manage, however, there are many hospitals in the world that can provide patients with the latest, cutting-edge treatments in order to give the best chance to fight against it. Doctors and scientists are always searching for and discovering new ways to treat cancer. According to InsiderMonkey, these are The 10 Best Cancer Treatment Hospitals In The World. 10. Peter Maccallum Health Centre, Australia Situated in Victoria, Australia, the Peter Maccallum Health Centre is the first public hospital in Australia that is solely dedicated to cancer patients. With more than 2,500 healthcare staff including over 580 clinical and laboratory researchers, Peter Mac is focused on providing better care, better treatments, and potential cures for cancer. Moorabbin, and Sunshine. 9. Oslo Comprehensive Cancer Centre, Norway At the heart of Oslo, Norway lies a high-tech cancer research facility. Located at the Oslo University Hospital, the Oslo Comprehensive Cancer Centre has more than 320 employees and seven research departments in its Institute for Cancer Research. Founded in 1954, the center boasts of its strong researches in the fields of biochemistry, cell and tumor biology, genetics, radiation biology, immunology, and cancer prevention. 8. Institut Gustave Roussy, France Located in Villejuif, France, the Institut Gustave Roussy is known as the premier European Cancer Centre. Innovation is at the core of this institution, leveraging scientific and technological advancements in the treatment of cancer. It was founded by Professor Gustave Roussy, the founding father of the cross-boundary working concepts and multidisciplinary patient management. 7. Netherlands Cancer Institute, The Netherlands Established in 1913, the Netherlands Cancer Institute (NKI) has been treating cancer patients for 103 years. With 650 scientists on board along with 185 specialists, this institute is no doubt one of the 10 best cancer hospitals in the world. It is the only hospital in the Netherlands solely dedicated for cancer. 6. Spanish National Cancer Research Center, Spain Located in Madrid, Spain, the Spanish National Cancer Research Center (CNIO) is known for applying technologically advanced treatments for cancer patients. 5. Roswell Park Cancer Institute, The US The Roswell Park Cancer Institute is the country’s first cancer center. Founded in 1898, the center takes pride in its multidisciplinary approach to treating cancer. The institute was built on the vision of eminent surgeon Dr. Roswell Park who rightfully predicted that cancer would become the leading cause of death in the U.S. and around the world. 4. Abramson Cancer Center, The US Located at the Hospital of the University of Pennsylvania, the Abramson Cancer Center is known for its innovation, cutting-edge technology, and translational medicine. It has one of the biggest clinical trial programs in the U.S. The Center has been named as “Translational Centers of Excellence” for lung, breast, blood, and pancreatic cancers. 3. Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, The US Headquartered in Baltimore, Maryland, the Johns Hopkins Hospital Sidney Kimmel Comprehensive Cancer Center is one of the premier cancer facilities in the U.S. It can accommodate more than 980 patients and has more than 46,600 admissions yearly. 2. Memorial Sloan Kettering Cancer Center, The US Located in New York City, the Memorial Sloan Kettering Cancer Center is one of the leading cancer hospitals in the country. It can accommodate more than 470 patients with over 24,000 admissions yearly. It was established in 1884 and was then known as New York Cancer Hospital. Memorial Sloan is known as the world’s oldest and largest private cancer center, treating patients for over 130 years. The strength of this hospital is their exceptional patient care, innovative research, and outstanding educational programs. They provide genetic counseling and psychological support to their cancer patients. Some of their leading cancer treatments include robot-assisted surgery, minimal access surgery, intraoperative radiation therapy, artemis intraoperative imaging technology, and immune checkpoint blockade therapy. 1. University of Texas MD Anderson Cancer Center, The US Recognized as the number one cancer hospital in the world, the University of Texas MD Anderson Cancer Center has a laser-focused mission to eliminate cancer in Texas, the country, and the world. It was established in 1941 by Monroe Dunaway Anderson, a banker and cotton trader who left a substantial amount of money for healthcare. Produced by: https://www.toptruths.com https://www.advexon.tv Contact us: https://www.facebook.com/toptruths/ Playlists: TOP Educational: https://goo.gl/Te6pVF TOP 10: https://goo.gl/csRZMy TOP Cotroversial: https://goo.gl/8kzcBg TOP Science & Tech: https://goo.gl/R3Rthw TOP TRUTHS: https://goo.gl/Rikg2D
Просмотров: 13261 TOP TRUTHS
Prostate Cancer Treatment at Penn Medicine -- Alan J. Wein, MD, PhD (Hon)
Proton therapy for prostate cancer is just one of the many treatment options available at Penn Medicine. In this video, you get to hear the unique perspective of Urologist, Alan J. Wein, Chief of the Division of Urology, on how a partnership with radiation oncology leads to the best possible outcomes for prostate cancer patients.
Просмотров: 498 Penn Medicine
Naomi B. Haas, MD, considers the role of TKIs in the treatment of renal cell cancer
Dr. Haas, Director, Prostate and Kidney Cancer Program, Associate Professor of Medicine at the Hospital of the University of Pennsylvania, shares the latest thinking regarding TKIs in the treatment of renal cell cancer.
Просмотров: 2 OBRoncology
Penn Radiation Oncology Center and the Proton Therapy Center’s History
From its early beginnings as a small team using the Van de Graaff generator to today’s department spanning multiple facilities with the most advanced cancer radiation technology in the world, the Penn Radiation Oncology Center has grown exponentially over the past 40 years. Follow Penn Medicine on Facebook: https://www.facebook.com/pennmed/ Follow Penn Medicine on Instagram: https://www.instagram.com/pennmedicine/ Tweet with us: https://twitter.com/PennMedicine
Просмотров: 227 Penn Medicine
Men's Prostate Cancer workshop 101
Black men come together to address the problem of Prostate Cancer. Nation Of Islam UK, health Conference, September 2009. Dr Frank Chinegwondoh, Senior lecturer, University of London, addresses all-men and boys workshop, at Muhammad Mosque London, looking at issues surrounding the male disease, prostate cancer.
Просмотров: 811 jetblakink
Dr. Anant Madabhushi - Development of mutli-modal prostate cancer screening technologies
Dr. Anant Madabhushi describes how his lab is working to develop cancer screening techniques that take synthesize data from different modalities. These modalities range from gene and protein expression to spectroscopy to histopathology and MRI. This synthesis creates a more complete representation of the cancer with which to make decisions about a patient's course of treatment. Dr. Anant Madabhushi, PhD, is the director of the Laboratory for Computational Imaging and Bioinformatics (LCIB) in the Department of Biomedical Engineering, Rutgers University. He is also a member of the Cancer Institute of New Jersey and an Adjunct Assistant Professor of Radiology at the Robert Wood Johnson Medical Center, NJ. He received his Bachelors Degree in Biomedical Engineering from Mumbai University, India in 1998 and his Masters in Biomedical Engineering from the University of Texas, Austin in 2000. In 2004 he obtained his PhD in Bioengineering from the University of Pennsylvania.
Просмотров: 2030 Rutgers University
Tom Guzzo, MD, MPH - Urologist, Penn Medicine
Watch an interview with Tom Guzzo, MD, a urologist at Penn Medicine. "I am a urologic oncologist. I treat patients with all aspects of urologic cancers, including; kidney, bladder, prostate and testicular cancer." "Here at Penn Medicine we have an innovative approach to cancer care including robotic surgery, proton therapy for prostate cancer, and complex laproscopic surgery. Not only do we do robotic surgery for prostate cancer, but our physicians also do robotic surgery for complex renal masses, including robotic-partial nephrectomy, and bladder cancer, including robotic-cystectomy with creation of neo bladders." "My practice is unique because I'm comfortable treating patients both open, robotic and laparoscopically, and therefore, I can give people an unbiased opinion with regard to what approach is best for the treatment of their cancer while maximizing their quality of life." "I'm Tom Guzzo. I'm Assistant Professor of Urology at Penn Medicine." Learn more about Dr. Guzzo: http://www.pennmedicine.org/Wagform/MainPage.aspx?config=provider&P=PP&ID=11437 To learn more, visit http://www.pennmedicine.org/urology
Просмотров: 6412 Penn Medicine
Protons with a Purpose
Ask anyone involved in the Roberts Proton Therapy Center at Penn Medicine’s Abramson Cancer Center—patient, physician, technician, engineer, receptionist, physicist—and they will have powerful personal stories to share about this unique facility and the people devoted to it.
Просмотров: 344 University of Pennsylvania
Dr. Haas on Adjuvant VEGF-Targeted Therapy in RCC
Naomi B. Haas, MD, director, Prostate and Kidney Cancer Program Associate Professor of Medicine at the Hospital of the University of Pennsylvania, discusses results of 2 ongoing clinical trials looking at adjuvant therapy options in renal cell carcinoma (RCC).
Просмотров: 147 OncLiveTV
What new prostate cancer research is being done at Penn State Hershey?
What new prostate cancer research Penn State Hershey working on? Jay D. Raman, M. D., Urologist, Penn State Cancer Institute
Просмотров: 70 PennStateHershey
Michael Metro, MD – Quality of Life Issues After Prostate Cancer Treatment – Temple Urology
Michael Metro, MD, Director of Reconstructive Urology at Temple University Hospital, discusses different interventions that can potentially improve quality of life for patients following surgery for prostate cancer. To schedule an appointment with Dr. Metro, call 1-800-TEMPLE-MED (1-800-836-7536). For more information about urology at Temple, visit: http://tuh.templehealth.org/content/urology.htm
Просмотров: 141 Temple Health
Naomi B. Haas, MD, on how immunotherapies are being integrated into kidney cancer treatment
Dr. Haas, Director, Prostate and Kidney Cancer Program, Associate Professor of Medicine at the Hospital of the University of Pennsylvania, discusses how immunotherapies are being integrated into the treatment of renal cell cancer.
Просмотров: 45 OBRoncology
Expert Opinion - How is Proton Therapy integrated into cancer care?
How is Proton Therapy integrated into cancer care? Dr. James Metz, Professor of Radiation Oncology at the University of Pennsylvania Health System Roberts Proton Therapy Center in Philadelphia, PA, USA, would like to see proton therapy integrated into the overall treatment path.
Просмотров: 242 Proton Therapy IBA
Naomi B. Haas, MD, on what clinical evidence can tell us about the adjuvant treatment of RCC
Dr. Haas, Director, Prostate and Kidney Cancer Program, Associate Professor of Medicine at the Hospital of the University of Pennsylvania, elaborates on what clinical evidence tells us about the adjuvant treatment of renal cell carcinoma (RCC) patients.
Просмотров: 3 OBRoncology
Roger E. Schultz, M.D.
Dr. Schultz earned his medical degree from the Mount Sinai School of Medicine. He completed residency training at the Hospital of the University of Pennsylvania. Dr. Schultz is board-certified by the American Board of Urology. Dr. Schultz specializes in the treatment of enlarged prostate, bladder cancer, kidney stones, male fertility issues and incontinence. He makes it a point to help patients fully understand their treatment, ensuring patients find the "value in the visit." Dr. Schultz believes in both an empathetic and constructive approach to care. Originally from New York City, he spends his free time kayaking, biking and making music - he plays the clarinet and piano and sings. He has traveled throughout the world on personal and humanitarian trips, developing his photography skills along the way. Dr. Schultz is married with two grown children.
Просмотров: 267 Riverside
Killer Cells Wipe Out Cancer
Medical experts are calling it a major breakthrough. Researchers at the University of Pennsylvania report they have successfully treated leukemia - a lethal blood cancer - by injecting patients with gene-altered immune-system cells that targeted and destroyed the cancer.
Просмотров: 502 VOA News
Immunotherapy for Pancreatic Cancer with Gregory Beatty
On November 20, 2014, Gregory Beatty, M.D., Ph.D., an assistant professor of medicine at the Perelman School of Medicine at the University of Pennsylvania and in the Division of Hematology/Oncology within the Abramson Cancer Center at the Hospital of the University of Pennsylvania, discussed the latest advancements in the development of immunotherapies to treat pancreatic cancer. This 45-minute online webinar is part of the Cancer Research Institute's Breakthroughs in Cancer Immunotherapy webinar series. These webinars are offered free to the public and feature informative updates from leaders in cancer immunotherapy, followed by a moderated Q&A. For more information on this webinar, or to register for upcoming webinars, please visit www.cancerresearch.org/webinars.
Просмотров: 3751 Cancer Research Institute
Dr. Ilia Zeltser - Pennsylvania Urologist - Bryn Mawr Urology Group
Dr. Zeltser received his bachelor's of science degree, Suma Cum Laude, from Brooklyn College and his medical degree with Distinction in Research from the State University of New York at Stony Brook School of Medicine. He completed both his general surgery and urology residencies at Thomas Jefferson University Hospital, in Philadelphia, Pennsylvania. He then completed a Fellowship in Minimally Invasive/Robotic Urologic Surgery at the University of Texas Southwestern Medical Center in Dallas, where he also served as Instructor in Urology. Currently Dr. Zeltser serves as a Clinical Assistant Professor of Urology at Thomas Jefferson University. Dr. Zeltser has an extensive experience in both "pure" laparoscopic and robotic (da Vinci) radical prostatectomies for prostate cancer as well as minimally invasive approaches to the treatment of kidney, bladder and testicular cancer. Dr. Zeltser is among an elite group of physicians nationwide and the only one in the Philadelphia region performing Laparoscopic Retroperitoneal Lymph Node Dissection, a safe and effective way to treat testicular cancer with decreased pain and faster recovery when compared to traditional surgical procedures. Dr. Zeltser's main clinical and research interests are in Endourology and the minimally invasive approaches to the treatment of kidney cancer and he has published numerous articles, abstracts and book chapters in the field of minimally invasive urology. Dr. Zeltser and colleagues reported the first ever single port scarless laparoscopic kidney removal. Dr. Zeltser is an active member of the American Urological Association, the Endourological Society and the American Medical Association. Dr. Zeltser is fluent in Russian. For more Information contact Bryn Mawr Urology Group 610.525.6580 http://www.BrynMawrUrology.com
Просмотров: 1347 Brynmawr Urology
Chair of Urology Leonard Gomella, MD
Urologist Leonard Gomella, MD, chair of Urology at Jefferson discusses treatment of patients with prostate cancer. Learn more about Jefferson's multidisciplinary approach to treatment: http://sm.tjuh.org/O6d
Просмотров: 503 JeffersonCloseUp
Naomi B. Haas, MD, on how patient characteristics play a role in sequencing in metastatic RCC
Dr. Haas, Director, Prostate and Kidney Cancer Program, Associate Professor of Medicine at the Hospital of the University of Pennsylvania, describes how patient characteristics play a role in selecting one agent over another when sequencing for metastatic RCC patients.
Просмотров: 7 OBRoncology
Low carb diet may slow growth of prostate cancer - IN60
From North Carolina - A diet low in carbohydrates may help to thwart the growth of prostate tumors. Researchers found that mice which were fed a low-carb diet had smaller tumors and survived longer than mice which were fed carbohydrate-rich foods. It is hypothesized that a reduction in insulin levels caused by the low-carb diet is responsible for slowing tumor growth. From Chicago - For the first time in over a decade, transplant recipients in three Chicago hospitals were infected with HIV by an organ donor. While the donor tested negative for HIV before the transplant, doctors speculate that the disease may have been contracted in the three weeks prior to the donor's death, rendering it undetectable. The Center for Disease Control and the Illinois Department of Public Health are investigating the case. From Montreal - Children with ADHD may suffer from a delay in the normal maturing of the brain. In a study performed by Canada's National Institute of Mental Health, peak thickness in the prefrontal cortex -- an area of the brain that controls attention and plans movement -- occurred three years late in those with ADHD. The finding serves to explain why many children seem to grow out of the disorder. And finally, from Pennsylvania - Curvy women -- those who have narrow waists and wide hips -- have a better chance of not only being smarter themselves, but also giving birth to smarter children. Researchers linked lower levels of upper-body fat and higher levels of lower-body fat to a better supply of fatty acids essential to neurodevelopment in women and their offspring. The result may also help to explain male preference for certain body shapes For Insidermedicine in 60, I'm Dr. Susan Sharma.
Просмотров: 6543 insidermedicine
Dr. Ilia Zeltser - Pennsylvania Urologist Bryn Mawr Urology Group
My specialty in our practice and my research interest is minimally invasive surgery for cancers of the prostate, kidney, bladder and testis. In addition to general urology training, I have completed a sub-specialty training in laparoscopic and robotic surgery. I would specifically would like to call your attention to a laparoscopic partial nephrectomy as well as needle-ablation techniques for the treatment of kidney cancer. Using these techniques I am able to treat the cancer without removing the entire kidney, thus preserving the long term kidney function and avoiding the need for dialysis or transplantation. These new procedures are associated with minimal pain and often do not require admission to the hospital at all. However, these surgeries are technically very complex and therefore are only available in a few university medical centers around the country. For more Information contact Bryn Mawr Urology Group 610.525.6580 http://www.BrynMawrUrology.com
Просмотров: 253 Brynmawr Urology
Special Alert: Using Virus For The Treatment Of Cancer
Click Here!! http://www.saturdaydiet.com for eCourses Special Alert: Immunotherapy For The Treatment Of Cancer Get FREE; 10 page Weight Loss eBook at http://www.joanBars.com Special Alert: Immunotherapy For The Treatment Of Cancer At Penn Medicine's Abramson Cancer Center, their medical oncologists are experts in the use of Immunotherapy for the treatment of cancer. Immunotherapy is a treatment that uses certain parts of the immune system to fight cancer or to lessen the side effects that may be caused by some cancer treatments. Immunotherapy is a treatment that uses certain parts of the immune system to fight cancer or to lessen the side effects that may be caused by some cancer treatments. Other terms used to describe immunotherapy include biologic response modifiers and biologic therapy. The program is headed by, Carl H. June, MD. The immune system is a network of cells and organs that work together to defend the body against attacks by foreign substances. This network is one of the body's main defenses against disease. It works against disease, including cancer, in many ways. For example, the immune system may recognize the difference between healthy cells and cancer cells and work to eliminate those that become cancerous. Cancer may develop when the immune system breaks down or is not functioning adequately. Immunotherapies are designed to repair, stimulate, or enhance the immune system's responses. Watch their video at: https://youtu.be/h6SzI2ZfPd4 This alert came from the series: Vice on HBO: http://killingcancer.vice.com/ The Hospital of the University of Pennsylvania- 1-800-789-PENN- Penn Medicine – Abramson Cancer Center- The Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104 Thanks for watching!! If you know someone who could benefit from this information, please feel free to forward it to them!! Bill and Joan Loganeski have discovered a meal replacement you can make at home for very little money and when combined with our Saturday Morning Diet plan it will help you lose the weight. The Saturday Morning Diet channel is our educational and information channel to help you use lose weight in a healthy way.weight loss, exercise, free, meals, meal plan, diets, program, easy, healthy, foods, quick, rapid, diet, health, how to lose weight http://www.youtube.com/subscription_center?add_user=joanloganeski
Просмотров: 64 Joan Diet Bars
Holmium laser enucleation of the prostate technique for benign prostatic hyperplasia
Douglas C. Kelly, MD, Akhil Das, MD Department of Urology, Thomas Jefferson University Hospital, Philadelphia Pennsylvania, USA Holmium laser resection of the prostate (HoLRP) was first described by Gilling et al in 1995. HoLRP has now evolved into holmium laser enucleation of the prostate (HoLEP) with the advent of the intravesical soft-tissue morcellator. The procedure involves anatomical dissection of the prostatic tissue off the surgical capsule in a retrograde fashion using a high-powered holmium laser followed by intravesical morcellation of the prostatic tissue. Some groups believe that the HoLEP procedure is the endoscopic equivalent to a simple open prostatectomy and may be superior to transurethral resection of the prostate (TURP) or even open prostatectomy. The objective of this article is to explain the techniques for holmium laser enucleation of the prostate (HoLEP). Read the full article http://canjurol.com/how-i-do-it.php © The Canadian Journal of Urology™; 19(1); February 2012
Просмотров: 53213 CanadianUrology
Ramji Rajendran MD,PhD Radiation Oncology Consultants Chicagocancer.org
Dr. Rajendran primarily practices at Alexian Brothers Cancer Center and Illinois Gamma Knife Center. He attended college at the University of Virginia and came to the Midwest for a combined MD/PhD program at the University of Illinois at Urbana-Champaign. Dr. Rajendran has a PhD in molecular mechanisms and cell biology of hormone dependent cancers such as breast cancer and prostate cancer. He did his residency training at the Hospital of the University of Pennsylvania in Philadelphia. He has also conducted research in the areas of prostate organ motion, proton radiation therapy, and radiation therapy for breast and thoracic tumors. He has written numerous papers and made presentations nationally and internationally. Dr. Rajendran is trained in the use of 3-dimensional conformal radiation therapy, intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), gamma knife radiosurgery, high dose rate brachytherapy, and permanent interstitial brachytherapy. He has interest in treating a broad range of cancers including breast, lung, brain, genitourinary, head and neck, and gynecologic malignancies. He is also interested in cancer survivorship issues and empowering cancer patients and their care givers. Dr. Rajendran enjoys spending his leisure time with his wife and two children camping, hiking, playing tennis, gourmet cooking, and wine tasting. When asked why he chose radiation oncology, he states, "I began my love of cancer biology by studying cancer cells and I learned in medical training the art of caring for the entire patient. I strive to continually gain clinical knowledge to properly stage, plan, and treat my patients based on clinical evidence. I want to give my patients a clear understanding of how and why I am treating them. To really help a patient, it is critical to understand the science behind their treatment and the art of delivering care." TREATMENT CENTERS Alexian Brothers Medical Center Illinois Gamma Knife Center at Alexian Brothers Medical Center
Просмотров: 556 Rad Onc
Naomi B. Haas, MD, offers opinion on the optimal sequencing of agents in treatment of RCC
Dr. Haas, Director, Prostate and Kidney Cancer Program, Associate Professor of Medicine at the Hospital of the University of Pennsylvania, discusses the optimal sequencing of agents in the treatment landscape for metastatic renal cell carcinoma (RCC).
Просмотров: 13 OBRoncology
Natural Cancer Treatment Centers: Dr Rozita Moshtagh ND
Dr. Rozita Moshtagh ND, Natural Breast, Prostate, Liver, Skin Cancer Treatment, Live Blood Cell Analysis, tel: 310 365 1556
Просмотров: 133 Dr. Rozita Moshtagh, ND
Dr. David J. Ellis, M.D. F.A.C.S. - Pennsylvania Urologist - Bryn Mawr Urology Group
Dr. David J. Ellis earned his undergraduate degree at LaSalle College and his medical degree at Jefferson Medical College with distinction. He completed his general surgery training at Kaiser Permanente Medical Center in San Francisco and then his urology residency at the Thomas Jefferson University Hospital in Philadelphia. Dr. Ellis has received special training in Laparoscopy, Extracorporeal Shockwave Lithotripsy, Laser, and Ultrasound applications. He currently serves as Clinical Assistant Professor of Urology at Jefferson Medical College and as Attending Physician at The Bryn Mawr Hospital. He has assumed multiple leadership positions in the medical community. He is a former member of the Medical Executive Committee of Main Line Health Hospitals and treasurer of the Medical Staff. Currently, while in full-time practice, Dr. Ellis serves as the president of Academic Urology of PA, LLC, the largest single group practice of Urology in Pennsylvania. He is certified by the American Board of Urology and is a Fellow of the American College of Surgeons. He has been voted "Top Physician" for many consecutive years. Dr. Ellis is a member of the Philadelphia Urological Society and the Urological Association of Pennsylvania, Inc. Dr. Ellis' special interests include: Prostate cancer, prostate disease, urinary malignancies, kidney stone therapy, and impotence. He particularly enjoys the mentoring of the next generation of urologists. He considers this activity his most important in enhancing care for all current and future patients. For more Information contact Bryn Mawr Urology Group 610.525.6580 http://www.BrynMawrUrology.com
Просмотров: 1377 Brynmawr Urology
Good People. Great Medicine. - Hope - Penn State Hershey Cancer Institute
What defines great cancer care? It's more than specialists working together. It's more than discovering promising treatments. It's more than treating every type of cancer. It's hope. Offering the latest treatment while discovering the next. It's what we do. Good People. Great Medicine. Penn State Hershey Cancer Institute.
Просмотров: 508 Penn State University
Creating the Roberts Proton Therapy Center at Penn Medicine
The Roberts Proton Therapy Center delivers the most precise form of advanced radiation therapy available. Proton therapy works by targeting a focused beam of high-dose radiation to a specific tumor site dramatically decreasing damage to surrounding normal tissue. This form of therapy results in fewer side effects and clinical complications for patients, and it enhances the physicians ability to more safely treat tumors close to critical organs and the spinal cord. To learn more about the Roberts Proton Therapy Center, visit http://www.pennmedicine.org/proton Approximately 75,000 square feet in size, the Robert Proton Therapy Center features five treatment rooms: four with treatment gantries and one fixed-beam room. The Center has the most advanced options available for patient positioning and comfort and will afford patients the opportunity to have multi-modality treatment with chemotherapy, surgery and other forms of radiation. The Center also has state-of-the-art research capabilities to assist our scientists in finding new and safer treatments for cancer patients. The Roberts Proton Therapy Center is expected to treat 3,000 patients a year, including several hundred children in partnership with The Children's Hospital of Philadelphia. Penn also has established a partnership with Walter Reed Army Medical Center, through which proton therapy technology will be available to treat United States military personnel. The Roberts Proton Therapy Center was made possible in part through a generous gift from the Roberts family. To learn more about the Roberts Proton Therapy Center, visit http://www.pennmedicine.org/proton
Просмотров: 2713 Penn Medicine
Latest in Cancer Treatment: CAR T Cell Journey with Dr Carl June Part 2
CureTalks.com is talking to immunotherapy pioneer Dr. Carl June of University of Pennsylvania. This part focuses on the panel discussion with Gary Petersen, Jack Aiello and Mike Scott. Dr. June shares his recent experience when he met 40 children who have been successfully treated with CAR-T therapy. He discusses how CD-19 could be a target for CAR-T cells and why CRISPR technique was used for gene editing in the therapy. He also gives a clinical trial update of CAR-T therapies especially for multiple myeloma patients. He explains how CAR-T cells can recognise more than one antigen and details of BITE technology. He briefly touches upon an ongoing trial for prostate cancer which is testing use of CAR-T therapy in solid tumors. This talk has been created by CureTalks.com, a social initiative by TrialX to facilitate discussions for solutions, with a mission to heal the world through information and sharing of knowledge. At CureTalks we discuss a wide range of medical, health, and wellness issues, bringing together the doctors, researchers and patients on the same platform.
Просмотров: 138 Cure Talks
Sidney Kimmel Cancer Center at Jefferson: Innovative Cancer Care Delivery
The Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation of the SKCC is the place where transformative advances in our knowledge of all aspects of blood cancers (causes, risk, diagnosis, prognosis, treatment, and survivorship) are taking place and new models in the delivery of personalized cancer care are being designed and implemented. http://www.SidneyKimmelCancerCenter.org
Просмотров: 457 WebsEdgeHealth
USA: Cancer-sniffing canines are a patient's new best friend
Video ID: 20140530-043 M/S Spaniel sniffs out samples around a table, Working Dog Centre at Pennsylvania University M/S Dog trainer vocally reward dog W/S Dog trainer rewards dog and throw a ball C/U Pictures of dogs on wall W/S Dog trainer vocally tells chocolate Labrador where to go M/S Chocolate Labrador sniffs samples around a table SOT: Dr. Cindy Otto, director of the Penn Vet Working Dog Centre (in English): "So all of the dogs here at the Vet Working Dog Centre are selected from families of dogs that are working dogs, so they have that natural proven ability for generations, that they can use their noses and use their noses well usually for hunting. So then within our centre we train the dogs with foundation skills, so they learn how to find things." W/S German Shepard sniffs one sample and is vocally rewarded by dog trainer SOT: Dr. Cindy Otto, director of the Penn Vet Working Dog Centre (in English): "And the way we are doing that is we are having her sniff a sample and when she takes a big sniff, we reward, we tell her what a good dog she is and she gets a treat. And so she learns in sniffing that sample the thing that earns her a treat and so she likes to do it, because she likes to get her treats." W/S Golden Retriever given treat by dog trainer C/U Golden Retriever gets given treat by dog trainer C/U 'Working dog centre' sign on wall W/S Exterior of dog centre with a field and a dog playing C/U Dog Working Centre sign, exterior of building W/S Exterior of Dog Working Centre, Pennsylvania University SCRIPT A group of 18 canines inhabiting the Working Dog Centre at Pennsylvania University on Friday were continuing a special training program in which they are being rewarded with treats to detect human cancer through their sense of smell. Using plasma samples from patients with cancer, along with healthy non-cancerous samples from humans, the dogs show the scientists how they can distinguish between the two. According to researchers at the university, the dogs' sense of smell, is able to identify the concentrations of alkanes and aromatic compounds generated by tumours. This means that once fully trained, the dogs will be able to detect internal diseases before they become evident. Facebook: http://www.facebook.com/Ruptly Twitter: http://twitter.com/Ruptly LiveLeak: http://www.liveleak.com/c/Ruptly Google Plus: http://plus.google.com/111498286331086224967 Instagram: http://www.instagram.com/Ruptly YouTube: http://www.youtube.com/user/RuptlyTV DailyMotion: http://www.dailymotion.com/ruptly Video on Demand: http://www.ruptly.tv
Просмотров: 863 Ruptly
Update on the IMPACT Study and Implications for Men with BRCA Mutations, March 27, 2012
Presented by Jacquelyn Powers, University of Pennsylvania. Discussion of IMPACT, an interational study that aims to discover whether screening to detect prostate cancer can be targeted at men who carry the BRCA1 and BRCA2 alterations, leading to an earlier diagnosis and improved survival.
Просмотров: 210 facingourrisk
Farjaad Siddiq, M.D.mov
Meet Dr. Farjaad Siddiq, Urologist for CHRISTUS St. Patrick Hospital Dr. Farjaad Siddiq is a board-certified urologist with fellowship training in endourology, laparoscopy and robotic surgery. As a minimally invasive surgeon, he is committed to surgical options that minimize incisions, pain, and recovery times for his patients. He has a special interest in urologic cancers and kidney stone disease. Dr. Siddiq grew up in Providence, Rhode Island. After graduating summa cum laude from Providence College, he obtained his medical degree from Brown University, graduating among the top of his class. He completed a general surgery internship and then a urology residency at Brown University and Affiliated Hospitals. After his residency, Dr. Siddiq trained as a fellow in endourology, laparoscopy, and robotic surgery at the University of Miami. Subsequently, Dr. Siddiq was recruited to join the Urology Center of SW Louisiana where he is a partner. He is Director of Robotic Surgery at CHRISTUS St. Patrick Hospital. Dr. Siddiq routinely performs laparoscopic and robotic surgery for kidney and prostate cancer and has extensive experience in the field. He serves as a reference and surgeon for other urologists with exceptionally difficult cases to manage. Dr. Siddiq has been a pioneer in minimally invasive urology in Louisiana. He was one of the first urologists in the state to perform laparoscopic and CT-guided radiofrequency ablation of kidney cancers and has trained other physicians in the technique. In addition, Dr. Siddiq was the first in the state to perform a robotic or da Vinci partial nephrectomy for kidney cancer. He was one of the first physicians in Louisiana to offer robotic prostatectomy for prostate cancer, performing the first da Vinci prostatectomy in Lake Charles in 2006. Dr. Siddiq is a Fellow of the American College of Surgeons. He is a member of the American Urological Association, the Endourology Society, and the Society of Laparoendoscopic Surgeons. He has published extensively in his field.
Просмотров: 843 CHRISTUSStPatrick
Kathleen Cooney, MD - Video Profile
Professor, Medical Oncology Specialties: Medical Oncology Clinical Interests: Hematology/Oncology and Genitourinary Oncology Dr. Kathleen Cooney received her undergraduate degree in biochemistry magna cum laude and Phi Beta Kappa at Dartmouth College in New Hampshire. She received her medical degree at the University of Pennsylvania School of Medicine and then moved on to the University of Michigan where she completed residency training in internal medicine and a fellowship in hematology/oncology. Dr. Cooney joined the U-M faculty in 1991, where her clinical interests are primarily in the medical management of prostate and bladder cancers. Dr. Cooney's research focuses on the identification of genetic defects in sporadic and hereditary forms of prostate cancer. She has established a clinical database to study the inheritance pattern of prostate cancer that has provided an infrastructure for hereditary prostate cancer research at the University of Michigan.
Просмотров: 822 Michigan Medicine
Expanding Access: First Clinical Trial Transplants Hepatitis C-Infected Kidneys at Penn Medicine
The investigational transplantation approach described in this video is being studied in an ongoing clinical trial. Safety and efficacy of this approach has not been established, and therefore it is still unknown whether these patients will be cured. The research team plans to publish their full results upon completion of the trial. The study is supported by a research grant from the Merck Investigator Initiated Studies Program. Read more at http://www.uphs.upenn.edu/news/News_Releases/2016/09/thinker/.
Просмотров: 1372 Penn Medicine News
MRI-Guided Focal Laser Ablation Therapy for Prostate Cancer
Men with early stage prostate cancer who previously had to choose between aggressive treatment -- with a greater risk for side effects -- and active surveillance, have a new treatment option; MRI-guided focal laser ablation. University of Chicago Medicine urologic oncologist Scott Eggener, MD, radiologist Aytekin Oto, MD, and patient Nick Kolliniatis talk about this innovative, outpatient treatment. Learn more: http://www.uchospitals.edu/specialties/cancer/urologic/prostate/treatment/focal-laser-ablation.html
Просмотров: 8578 UChicago Medicine
Linds Ringing the Bell at Penn Medicine!
My chance to RING THE BELL at the Perelman Center for Advanced Medicine, University of Pennsylvania Hospital, after completing weeks and weeks of Proton Beam Radiation at the Roberts Proton Therapy Center.
Просмотров: 125 Lindsey Price Jackson
Runner hit by deer becomes honorary race captain for ZERO Prostate Cancer Run
Original airdate: 8/21/2017 | BETHLEHEM, Pa. - A viral video of a deer ramming into a runner got a young man from our area national attention. But it was that video that has made him front and center of a fundraiser to fight prostate cancer. Justin DeLuzio was hit by the deer and the collision was captured. "He hit me in the chest and I landed on my back," said DeLuzio. The Gwynedd Mercy University senior managed to get up and finish the race, only because his teammates never left his side. After seeing the video, Dr. Joseph Trapasso knew Justin would be perfect as an honorary race captain for the upcoming ZERO Prostate Cancer Run/Walk. Full story: http://www.wfmz.com/news/lehigh-valley/runner-hit-by-deer-in-viral-video-back-in-lehigh-valley-for-a-good-cause/607606495 Eric Bologa's original viral video post: https://www.facebook.com/platypuskid93/videos/10207780939667044/
Просмотров: 57 69News WFMZ-TV